SCOPUS 정보 검색 플랫폼

Volumn 5, Issue 1, 2012, Pages 73-75

Trent of spinal muscolar atrophy with intrathecal mesenchymal cells

Author keywords

Mesenchymal; SMA1; Stem cells

Indexed keywords

EID: 84875255096 PISSN: 20053606 EISSN: 20055447 Source Type: Journal
DOI: 10.15283/ijsc.2012.5.1.73 Document Type: Article

Times cited : (3)

References (7)

1
- 38349090169
- Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells
- Angelozzi C, Borgo F, Tiziano FD, Martella A, Neri G, Brahe C. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. J Med Genet 2008;45:29-31
- (2008) J Med Genet , vol.45 , pp. 29-31
- Angelozzi, C.¹ Borgo, F.² Tiziano, F.D.³ Martella, A.⁴ Neri, G.⁵ Brahe, C.⁶

2
- 84864050619
- Drug treatment for spinal muscular atrophy type I
- Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF. Drug treatment for spinal muscular atrophy type I. Cochrane Database Syst Rev 2011;(12):CD006281
- (2011) Cochrane Database Syst Rev , Issue.12
- Wadman, R.I.¹ Bosboom, W.M.² van den Berg, L.H.³ Wokke, J.H.⁴ Iannaccone, S.T.⁵ Vrancken, A.F.⁶

3
- 84856258407
- Drug treatment for spinal muscular atrophy types II and III
- Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF. Drug treatment for spinal muscular atrophy types II and III. Cochrane Database Syst Rev 2011;(12):CD006282
- (2011) Cochrane Database Syst Rev , Issue.12
- Wadman, R.I.¹ Bosboom, W.M.² van den Berg, L.H.³ Wokke, J.H.⁴ Iannaccone, S.T.⁵ Vrancken, A.F.⁶

4
- 65849222556
- Phase II open label study of valproic acid in spinal muscular atrophy
- Swoboda KJ, Scott CB, Reyna SP, Prior TW, LaSalle B, Sorenson SL, Wood J, Acsadi G, Crawford TO, Kissel JT, Krosschell KJ, D'Anjou G, Bromberg MB, Schroth MK, Chan GM, Elsheikh B, Simard LR. Phase II open label study of valproic acid in spinal muscular atrophy. PLoS One 2009;4:e5268
- (2009) PLoS One , vol.4
- Swoboda, K.J.¹ Scott, C.B.² Reyna, S.P.³ Prior, T.W.⁴ LaSalle, B.⁵ Sorenson, S.L.⁶ Wood, J.⁷ Acsadi, G.⁸ Crawford, T.O.⁹ Kissel, J.T.¹⁰ Krosschell, K.J.¹¹ D'Anjou, G.¹² Bromberg, M.B.¹³ Schroth, M.K.¹⁴ Chan, G.M.¹⁵ Elsheikh, B.¹⁶ Simard, L.R.¹⁷

5
- 67449135902
- Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy
- Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, Lutz GJ. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. J Neurosci 2009;29: 7633-7638
- (2009) J Neurosci , vol.29 , pp. 7633-7638
- Williams, J.H.¹ Schray, R.C.² Patterson, C.A.³ Ayitey, S.O.⁴ Tallent, M.K.⁵ Lutz, G.J.⁶

6
- 84857125246
- Mesenchymal stem cells for treatment of CNS injury
- Azari MF, Mathias L, Ozturk E, Cram DS, Boyd RL, Petratos S. Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol 2010;8:316-323
- (2010) Curr Neuropharmacol , vol.8 , pp. 316-323
- Azari, M.F.¹ Mathias, L.² Ozturk, E.³ Cram, D.S.⁴ Boyd, R.L.⁵ Petratos, S.⁶

7
- 0036194714
- Motor unit number estimation in infants and children with spinal muscular atrophy
- Bromberg MB, Swoboda KJ. Motor unit number estimation in infants and children with spinal muscular atrophy. Muscle Nerve 2002;25:445-447
- (2002) Muscle Nerve , vol.25 , pp. 445-447
- Bromberg, M.B.¹ Swoboda, K.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.